132 related articles for article (PubMed ID: 31436179)
21. Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy.
Shin DH; Glover BK; Cha SC; Kim YY; Kim C; Nguyen KD
Am J Ophthalmol; 1999 May; 127(5):511-5. PubMed ID: 10334342
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms underlying acute angle closure.
Nongpiur ME; Aung T
Clin Exp Ophthalmol; 2017 May; 45(4):331-332. PubMed ID: 28618456
[No Abstract] [Full Text] [Related]
23. Acute angle-closure glaucoma with choroidal effusion revealing a hantavirus infection: Description of ultrasound biomicroscopy imagery and optical coherence tomography Visante.
Baillieul A; Le TL; Rouland JF
Eur J Ophthalmol; 2021 Jan; 31(1):NP4-NP8. PubMed ID: 31256684
[TBL] [Abstract][Full Text] [Related]
24. Intra-ocular pressure fluctuation after cataract surgery in primary angle-closure glaucoma eyes medically controlled after laser iridotomy.
Özyol P; Özyol E; Sül S; Baldemir E; Çavdar S
Acta Ophthalmol; 2016 Nov; 94(7):e528-e533. PubMed ID: 27040022
[TBL] [Abstract][Full Text] [Related]
25. Sensitization to and allergic contact dermatitis caused by Mirvaso(®) (brimonidine tartrate) for treatment of rosacea - 2 cases.
Bangsgaard N; Fischer LA; Zachariae C
Contact Dermatitis; 2016 Jun; 74(6):378-9. PubMed ID: 27133629
[No Abstract] [Full Text] [Related]
26. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
[TBL] [Abstract][Full Text] [Related]
27. Chronic angle-closure glaucoma.
Salmon JF; Sharma T
Ophthalmology; 2005 Oct; 112(10):1844. PubMed ID: 16199271
[No Abstract] [Full Text] [Related]
28. Adverse effects of brimonidine eye drop in children: A case series.
Ghaffari Z; Zakariaei Z; Ghazaeian M; Jafari R; Ezoddin N; Yousefi Nouraee H; Navaeifar MR
J Clin Pharm Ther; 2021 Oct; 46(5):1469-1472. PubMed ID: 33626597
[TBL] [Abstract][Full Text] [Related]
29. [Brimonidine and acute anterior granulomatous uveitis: A case report and literature review].
Comet A; Donnadieu B; Courjaret JC; Gascon P; Denis D; Matonti F
J Fr Ophtalmol; 2017 Apr; 40(4):e127-e129. PubMed ID: 28336279
[No Abstract] [Full Text] [Related]
30. Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema.
Cookson H; McFadden J; White J; White IR
Contact Dermatitis; 2015 Dec; 73(6):366-7. PubMed ID: 26768997
[No Abstract] [Full Text] [Related]
31. Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.
Mizoue S; Nitta K; Shirakashi M; Nitta A; Yamabayashi S; Kimura T; Ueda T; Takeda R; Matsumoto S; Yoshikawa K
Adv Ther; 2017 Jun; 34(6):1438-1448. PubMed ID: 28508306
[TBL] [Abstract][Full Text] [Related]
32. Effect of Brimonidine on the B Cells, T Cells, and Cytokines of the Ocular Surface and Aqueous Humor in Rat Eyes.
Shin HY; Lee HS; Lee YC; Kim SY
J Ocul Pharmacol Ther; 2015 Dec; 31(10):623-6. PubMed ID: 26401980
[TBL] [Abstract][Full Text] [Related]
33. Anterior segment imaging and the intraocular pressure lowering effect of cataract surgery for open and narrow angle glaucoma.
Kronberg BP; Rhee DJ
Semin Ophthalmol; 2012; 27(5-6):149-54. PubMed ID: 23163269
[TBL] [Abstract][Full Text] [Related]
34. α2-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model.
Jung KI; Kim JH; Park CK
Eur J Pharmacol; 2015 Oct; 765():274-83. PubMed ID: 26300392
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of brimonidine in preventing intraocular pressure elevation in the provocative test for primary angle-closure glaucoma.
Chen YF; Hung PT; Hsieh JW; Shein J; Hsiao CK
J Ocul Pharmacol Ther; 2002 Apr; 18(2):99-103. PubMed ID: 12002673
[TBL] [Abstract][Full Text] [Related]
36. Bilateral angle closure following use of a weight loss combination agent containing topiramate.
Grewal DS; Goldstein DA; Khatana AK; Tanna AP
J Glaucoma; 2015; 24(5):e132-6. PubMed ID: 25304279
[TBL] [Abstract][Full Text] [Related]
37. Determination of anterior segment changes with Pentacam after phacoemulsification in eyes with primary angle-closure glaucoma.
Zhao Q; Li NY; Zhong XW
Clin Exp Ophthalmol; 2012 Nov; 40(8):786-91. PubMed ID: 22594460
[TBL] [Abstract][Full Text] [Related]
38. [Hypotensive effect of three different formulations of brimonidine tartrate in normal eyes].
Abud TB; Scuoteguazza Filho M; Oliveira ES; Abud JF; Prata Junior JA
Arq Bras Oftalmol; 2013; 76(2):69-71. PubMed ID: 23828464
[TBL] [Abstract][Full Text] [Related]
39. Dark room provocative test and extent of angle closure: an anterior segment OCT study.
Wang B; Congdon NG; Wang N; Lei K; Wang L; Aung T
J Glaucoma; 2010 Mar; 19(3):183-7. PubMed ID: 19593203
[TBL] [Abstract][Full Text] [Related]
40. Can we screen for angle closure?
Sakata LM; Aung T
Am J Ophthalmol; 2011 Apr; 151(4):567-8. PubMed ID: 21420519
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
